Protection against lipopolysaccharide-induced sepsis and inhibition of interleukin-1 and prostaglandin E2 synthesis by silymarin

By Kang J.S.   Jeon Y.J.   Park S.-K.   Yang K.-H.   Kim H.M.  

Biochemical Pharmacology, Vol. 67, Iss. 1, 2004-01 ,pp. : 175-181

Elsevier

Access to resources Recommend Favorite

Effect of chronic treatment with perazine on lipopolysaccharide-induced interleukin-1β levels in the rat brain

By Obuchowicz Ewa   Marcinowska Agnieszka   Drzyzga Łukasz   Wójcikowski Jacek   Daniel Władysława   Herman Zbigniew  

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 373, Iss. 1, 2006-04 ,pp. : 79-84

Springer Publishing Company

Access to resources Recommend Favorite

Interleukin-1 receptor antagonist displays intrinsic agonist activity on rat gastric fundus motility in vitro

By Montuschi P.   Tringali G.   Mirtella A.   Parente L.   Preziosi P.   Navarra P.  

European Journal of Pharmacology, Vol. 282, Iss. 1, 1995-08 ,pp. : 263-263

Elsevier

Access to resources Recommend Favorite

Interleukin-1 receptor antagonist displays intrinsic agonist activity on rat gastric fundus motility in vitro

By Montuschi P.   Tringali G.   Mirtella A.   Parente L.   Preziosi P.   Navarra P.  

European Journal of Pharmacology, Vol. 275, Iss. 1, 1995-02 ,pp. : 31-37

Elsevier

Access to resources Recommend Favorite

Inhibition of lipopolysaccharide/ATP-induced release of interleukin-18 by KN-62 and glyburide

By Muhl H.   Hofler S.   Pfeilschifter J.  

European Journal of Pharmacology, Vol. 482, Iss. 1, 2003-12 ,pp. : 325-328

Elsevier

Access to resources Recommend Favorite